NCT07788157
Effects of Fospropofol Disodium TIVA and IVIH on Surgical Field Quality in Adult ESS
At risk: Primary completion moved 3 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Primary completion pushed from Sep 30, 2026 to Dec 30, 2026
Notable Recruitment opened Show 6 more changesShow less
- Eligibility criteria expanded, about 12 words
- Primary completion moved earlier from Dec 31, 2026 to Sep 30, 2026
- Study completion moved earlier from Jan 31, 2027 to Dec 31, 2026
- Study sites: 0 to 1
- Start date changed from estimate of Aug 1, 2026 to Jul 12, 2026
- Secondary endpoints: 10 to 9
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
The score of the Wormald scale
Timeframe: From the start of surgery to the end of surgery
The score of the Boezaart scale
Timeframe: From the start of surgery to the end of surgery
Secondary (9)
Total blood loss
The rate of bleeding
Induction time
Extubation time
Emergence time
Show 4 moreShow less
PACU length of stay
Emergence agitation
Postoperative pain score
Postoperative nausea and vomiting (PONV)
Arms and interventions
Group PActive comparator
Propofol induction (1-2 mg/kg) and propofol maintenance (5-12 mg/kg/h).
Group FExperimental
Fospropofol disodium induction (10-20 mg/kg) and fospropofol disodium maintenance (5-12 mg/kg/h).
Group PSExperimental
Propofol induction (1-2 mg/kg) and maintenance with propofol plus sevoflurane (1.0%).
Group FSExperimental
Fospropofol disodium induction (10-20 mg/kg) and maintenance with fospropofol disodium plus sevoflurane (1.0%).
Drugs: Fospropofol disodium, Propofol
Sites
1 site in 1 country
- Tongji HospitalWuhan, Hubei, China